MediQ Star Secures Seed Investment from GenAxis

Funding Rounds

▤ Summary

MediQStar announced it secured a seed investment from accelerator GenAxis (amount undisclosed). The startup develops generative-AI-based AI CRO technologies and a tuberculosis diagnostic kit called MycoScan. The kit reduces tests from three to one and cuts diagnosis time from 30 days to seven, and the company plans to begin domestic sales and expand to Vietnam. Mediqstar will use early diagnostic kit revenue to accelerate R&D and advance its AI CRO model to streamline clinical trials.

$ Funding

$
Amount None Total raised
□
Date January 13, 2025 Announcement date
◎
Investors - Lead investors
▥
Company mediqstar.com Funded company

▥ Classifications

industries
No industries detected
applications
AI & Machine learning

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies